Related Experiment Video
Updated: Jun 20, 2026
07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Biomarkers in GIST: partly ready for prime-time use
1University of British Columbia and the British Columbia Cancer Agency, Vancouver, British Columbia, Canada. cblanke@bccancer.bc.ca
Abstract:
Gastrointestinal stromal tumors, or GISTs, are now among the most treatable of solid malignancies. Assessing actual tumor response remains challenging; however, in this issue of Clinical Cancer Research, two articles discuss biomarkers potentially helpful in predicting response or other long-term benefits with standard tyrosine kinase therapy use.
